Stathmin 1 is highly expressed and is inhibited by paclitaxel in acute lymphoblastic leukemia cells (2017)
- Authors:
- USP affiliated authors: MACHADO NETO, JOÃO AGOSTINHO - ICB ; SIMOES, BELINDA PINTO - FMRP ; REGO, EDUARDO MAGALHÃES - FMRP ; TRAINA, FABÍOLA - FMRP
- Unidades: ICB; FMRP
- Subjects: LEUCEMIA; FENÓTIPOS; FOSFOPROTEÍNAS; PROLIFERAÇÃO CELULAR; ONCOPROTEÍNAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Rio de Janeiro
- Date published: 2017
- Source:
- Título: Revista Brasileira de Hematologia e Hemoterapia
- ISSN: 1516-8484
- Volume/Número/Paginação/Ano: v. 39, suppl. 1, p. S115-S116, res. 318, 2017
- Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO 2017)
-
ABNT
MACHADO NETO, João Agostinho et al. Stathmin 1 is highly expressed and is inhibited by paclitaxel in acute lymphoblastic leukemia cells. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf. Acesso em: 12 fev. 2026. , 2017 -
APA
Machado Neto, J. A., Alves, A. P. N. R., Fernandes, J. C., Silva, J. L. C. da, Scopim-Ribeiro, R., Fenerich, B. A., et al. (2017). Stathmin 1 is highly expressed and is inhibited by paclitaxel in acute lymphoblastic leukemia cells. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Instituto de Ciências Biomédicas, Universidade de São Paulo. Recuperado de https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf -
NLM
Machado Neto JA, Alves APNR, Fernandes JC, Silva JLC da, Scopim-Ribeiro R, Fenerich BA, Silva FB da, Simões BP, Rego EM, Traina F. Stathmin 1 is highly expressed and is inhibited by paclitaxel in acute lymphoblastic leukemia cells [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39 S115-S116.[citado 2026 fev. 12 ] Available from: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf -
Vancouver
Machado Neto JA, Alves APNR, Fernandes JC, Silva JLC da, Scopim-Ribeiro R, Fenerich BA, Silva FB da, Simões BP, Rego EM, Traina F. Stathmin 1 is highly expressed and is inhibited by paclitaxel in acute lymphoblastic leukemia cells [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39 S115-S116.[citado 2026 fev. 12 ] Available from: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf - Padronização de modelo xenográfico sistêmico de leucemia linfoide aguda
- High cyclin D1 expression negatively impacts adult acute lymphoblastic leukemia outcomes
- IRS1/β-catenin axis is activated and induces MYC expression in acute lymphoblastic leukemia cells
- Activation of IRS1/beta-catenin axis in acute lymphoblastic leukemia
- Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells
- Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms
- Metformin reduces tumor burden and splenomegaly in JAK2V617F murine models
- Stathmin 1 is highly expressed in acute promyelocytic leukemia and microtubule dynamics is a potential target for ATRA-resistant APL cells
- The pharmacological IGF1R-IRS1/2 inhibitor NT157 presents multiple anti-neoplastic effects in myeloproliferative neoplasms
- Stathmin 1 é altamente expressa em leucemia promielocítica aguda e a dinâmica dos microtúbulos é um alvo potencial para células PML-RAR resistentes ao atra
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
